000 01469 a2200433 4500
005 20250516121620.0
264 0 _c20130717
008 201307s 0 0 eng d
022 _a1462-0332
024 7 _a10.1093/rheumatology/kes293
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aYap, Desmond Y H
245 0 0 _aLong-term data on corticosteroids and mycophenolate mofetil treatment in lupus nephritis.
_h[electronic resource]
260 _bRheumatology (Oxford, England)
_cMar 2013
300 _a480-6 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAdult
650 0 4 _aAnti-Inflammatory Agents
_xtherapeutic use
650 0 4 _aDisease-Free Survival
650 0 4 _aDrug Therapy, Combination
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aImmunosuppressive Agents
_xtherapeutic use
650 0 4 _aLongitudinal Studies
650 0 4 _aLupus Nephritis
_xdrug therapy
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aMycophenolic Acid
_xanalogs & derivatives
650 0 4 _aPrednisolone
_xtherapeutic use
650 0 4 _aRetrospective Studies
650 0 4 _aTreatment Outcome
650 0 4 _aYoung Adult
700 1 _aMa, Maggie K M
700 1 _aMok, Maggie M Y
700 1 _aTang, Colin S O
700 1 _aChan, Tak Mao
773 0 _tRheumatology (Oxford, England)
_gvol. 52
_gno. 3
_gp. 480-6
856 4 0 _uhttps://doi.org/10.1093/rheumatology/kes293
_zAvailable from publisher's website
999 _c22260332
_d22260332